{"name": "APIM Therapeutics",
 "permalink": "apim-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/apim-therapeutics",
 "homepage_url": "http://www.apimtherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "contact@apimtherapeutics.com",
 "phone_number": "",
 "description": "",
 "created_at": "Tue Mar 22 04:08:51 UTC 2011",
 "updated_at": "Fri Nov 11 04:23:59 UTC 2011",
 "overview": "\u003Cp\u003EAPIM Therapeutics is based on an original discovery by Prof. Marit Otterlei and co-inventors at the Department of Cancer Research and Molecular Medicine at NTNU (Trondheim, Norway). The company is currently developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen), a key DNA repair protein regulating cellular responses to DNA damage and stress. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       82],
      "assets/images/resized/0012/7179/127179v1-max-150x150.jpg"],
     [[250,
       136],
      "assets/images/resized/0012/7179/127179v1-max-250x250.jpg"],
     [[338,
       185],
      "assets/images/resized/0012/7179/127179v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Konstantinos",
      "last_name": "Alevizopoulos",
      "permalink": "konstantinos-alevizopoulos",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/11/apim-therapeutics-raises-additional-funding.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "APIM Therapeutics Raises Additional Funding",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2011,
    "funded_month": 11,
    "funded_day": 10,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Birk Venture",
         "permalink": "birk-venture",
         "image":
          {"available_sizes":
            [[[150,
               68],
              "assets/images/resized/0018/2549/182549v1-max-150x150.jpg"],
             [[247,
               113],
              "assets/images/resized/0018/2549/182549v1-max-250x250.jpg"],
             [[247,
               113],
              "assets/images/resized/0018/2549/182549v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sarsia Seed Management",
         "permalink": "sarsia-seed-management",
         "image":
          {"available_sizes":
            [[[150,
               80],
              "assets/images/resized/0010/3644/103644v2-max-150x150.jpg"],
             [[170,
               91],
              "assets/images/resized/0010/3644/103644v2-max-250x250.jpg"],
             [[170,
               91],
              "assets/images/resized/0010/3644/103644v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "c/o NTNU Technology Transfer AS ",
    "address2": "Sem S\u00c3\u00a6landsvei 14, Kjemiblokk 1, 3etg ",
    "zip_code": "N-7491",
    "city": "Trondheim ",
    "state_code": null,
    "country_code": "NOR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}